← Back to Analyst Consensus 
ADIL Buy
ADIAL PHARMACEUTICALS, INC.
Current Price —
Implied Upside —
Analysts 10
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 3, 2026 | Alliance Global Partners | initiate | — → Buy | — | 41% |
| Jun 15, 2026 | LUCID CAPITAL MARKETS | initiate | — → Buy | — | 32% |
| Sep 30, 2025 | Maxim Group | upgrade | Hold → Buy | $1.5 | 42% |
| Nov 14, 2024 | Rodman & Renshaw | initiate | — → Buy | $8 | 40% |
Price Target Trend
Apr 9, 2026 Oct 26, 2026
EPS Estimates
+1q —
0q —
+1y —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days